May 21, 2026 • 8:00 am EDT Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
May 14, 2026 • 8:00 am EDT Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
May 12, 2026 • 8:00 am EDT Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
May 5, 2026 • 8:00 am EDT Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026
Apr 22, 2026 • 8:00 am EDT Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Apr 14, 2026 • 8:00 am EDT Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Apr 7, 2026 • 8:00 am EDT Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Mar 18, 2026 • 8:00 am EDT Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
Mar 9, 2026 • 7:30 am EDT Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update